Topic: EPO

March 21, 2021

EPO Guidelines for Examination: Patentability of antibodies

The latest changes to the EPO Guidelines for Examination provide several updates to (i) the patent protection of antibodies, and (ii) the interpretation

March 8, 2021

Updates to the EPO Guidelines for Examination: Patentability of plants and animals, human-derived cells, and methods of treatment by therapy

The latest changes to the EPO Guidelines for Examination provide several updates in relation to the patent protection of (i) plants and

July 19, 2020

Patentability of simulations – Decision of the Enlarged Board of Appeal for G1/19.

The thorny issue of the patentability (or otherwise) of inventions involving computer simulations at the EPO has been provided with an ending,

June 17, 2020

Reaffirmation of the Allowability of Technical Implementations of Business Methods at the EPO

On 3 April 2020, the Technical Board of Appeal of the European Patent Office issued a decision for Appeal T1749/14 against refusal

June 10, 2020

Special reasons? Remittals from the EPO Boards of Appeal

One of the changes to the Rules of Procedure of the Boards of Appeal (RPBA) which came into force on 1 January

June 4, 2020

The EPO rules that plants and animals exclusively obtained by essentially biological processes are not patentable

The Enlarged Board of Appeal (EBA) of the EPO has confirmed in decision G3/19 that plants, plant material or animals exclusively obtained

February 17, 2020

Description Amendments Required by the EPO

The EPO’s updated Guidelines for Examination for March 2021 introduces a significant change regarding amendments required to the description before a European